Pages that link to "Q34634756"

The following pages link to Staging of prostate cancer (Q34634756):

Displaying 47 items.

• Urinary melatonin-sulfate/cortisol ratio and the presence of prostate cancer: A case-control study (Q28383609) (← links)
• Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6 (Q28544996) (← links)
• Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration. (Q30009388) (← links)
• Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis (Q33725877) (← links)
• DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells (Q33805578) (← links)
• Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time (Q35188264) (← links)
• Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy. (Q35823413) (← links)
• Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer (Q36021088) (← links)
• Completeness of prostate cancer staging in the Danish Cancer Registry, 2004-2009 (Q36194042) (← links)
• Functional variants of the 5-methyltetrahydrofolate-homocysteine methyltransferase gene significantly increase susceptibility to prostate cancer: Results from an ethnic Han Chinese population (Q37390418) (← links)
• MTHFR c.677C>T Inhibits Cell Proliferation and Decreases Prostate Cancer Susceptibility in the Han Chinese Population in Shanghai. (Q37397446) (← links)
• Single-nucleotide polymorphism rs1058205 of KLK3 is associated with the risk of prostate cancer: A case-control study of Han Chinese men in Northeast China (Q37696887) (← links)
• Prostate cancer: towards the standardization and synthesis of morphology, genetics, and prognosis (Q37972696) (← links)
• Patented prostate cancer biomarkers. (Q38023110) (← links)
• Senescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer. (Q38207592) (← links)
• Multiparametric MRI in prostate cancer management. (Q38212715) (← links)
• Variation between specialist uropatholgists in reporting extraprostatic extension after radical prostatectomy. (Q38384899) (← links)
• TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer. (Q38601602) (← links)
• Lymph node staging in prostate cancer: perspective for the pathologist (Q38935725) (← links)
• Prevalence and management of prostate cancer among East Asian men: Current trends and future perspectives. (Q38950711) (← links)
• Impact of the extent of extraprostatic extension defined by Epstein's method in patients with negative surgical margins and negative lymph node invasion (Q39613409) (← links)
• Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer. (Q39736576) (← links)
• Intranodal signal suppression in pelvic MR lymphography of prostate cancer patients: a quantitative comparison of ferumoxtran-10 and ferumoxytol (Q41543779) (← links)
• Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens (Q41701983) (← links)
• Alternatively activated macrophages are associated with metastasis and poor prognosis in prostate adenocarcinoma (Q42438837) (← links)
• Potential of asphericity as a novel diagnostic parameter in the evaluation of patients with 68Ga-PSMA-HBED-CC PET-positive prostate cancer lesions (Q43119026) (← links)
• CCAFU Recommendations 2013: Prostate cancer (Q43440505) (← links)
• Histological step sectioning of pelvic lymph nodes increases the number of identified lymph node metastases. (Q43546775) (← links)
• Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis. (Q43725536) (← links)
• Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer (Q43872198) (← links)
• Relationship of Mitochondrial Enzymes to Fatigue Intensity in Men With Prostate Cancer Receiving External Beam Radiation Therapy. (Q45022467) (← links)
• Combined handling of prostate base/bladder neck and seminal vesicles in radical prostatectomy specimens: our approach with the whole mount technique (Q45036398) (← links)
• Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of (131)I-L19SIP in a prostate cancer patient (Q45094027) (← links)
• CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer. (Q47139746) (← links)
• Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasis (Q47209579) (← links)
• Functional and Targeted Lymph Node Imaging in Prostate Cancer: Current Status and Future Challenges. (Q47829959) (← links)
• The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer (Q48919141) (← links)
• TMPRSS2-ERG gene fusion is rare compared to PTEN deletions in stage T1a prostate cancer (Q51586225) (← links)
• [TNM-Classification of localized prostate cancer : The clinical T-category does not correspond to the required demands]. (Q52845302) (← links)
• Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas. (Q53578113) (← links)
• Nicotinamide N-methyltransferase enhances the progression of prostate cancer by stabilizing sirtuin 1. (Q55432621) (← links)
• Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score (Q56978263) (← links)
• Imaging of distant metastases of prostate cancer (Q57108639) (← links)
• Cognitive function, depression, and anxiety in patients undergoing radical prostatectomy with and without adjuvant treatment (Q64073586) (← links)
• Advances in Urologic Imaging: Prostate-Specific Membrane Antigen Ligand PET Imaging (Q90383126) (← links)
• Increased Soluble CMG2 Serum Protein Concentration is Associated with the Progression of Prostate Carcinoma (Q92257350) (← links)
• MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? (Q98895639) (← links)